The latest news on the prevention, detection, diagnosis, and prognosis of cancer, and treatment modalities including chemotherapy, surgery, radiotherapy, and hormone therapy.
General oncology
Browse Archive: 
06 October 2015
Clinical trial results suggest significant benefits with the use of cabozantinib or nivolumab over everolimus for patients with advanced renal cell carcinoma, researchers reported at the European Cancer Congress in Vienna, Austria.
05 October 2015
Subgroups of advanced melanoma patients with a poor prognosis derive a progression-free survival benefit from the combination of nivolumab and ipilimumab, according to research presented at the European Cancer Congress in Vienna, Austria.
02 October 2015
A Canadian research team reports a substantial increase in the use of preoperative magnetic resonance imaging over a 10-year period in women with newly diagnosed breast cancer.
24 September 2015
Patient-reported fatigue severity is an independent prognostic marker for survival in patients with newly diagnosed intermediate-2- or high-risk myelodysplastic syndromes, according to research published in The Lancet Oncology.
21 September 2015
The use of arsenic trioxide instead of idarubicin in combination with all-trans retinoic acid is a feasible option in patients with acute promyelocytic leukaemia, regardless of risk level, suggests a phase III trial.
17 September 2015
Switching sunitinib treatment from a 4/2 to a modified 2/1 schedule can improve the tolerability profile for patients with metastatic renal cell carcinoma, say researchers.
17 September 2015
US researchers find no significant difference in survival outcomes between patients with small renal masses who opt for active surveillance and those who choose immediate treatment.
17 September 2015
In metastatic renal cell carcinoma patients, there is no significant correlation between adverse event profiles of first- and second-line tyrosine kinase inhibitors, suggests a Japanese study.
Friendly links

Follow me on Twitter